Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Endocrine ; 78(1): 197-200, 2022 10.
Article in English | MEDLINE | ID: covidwho-2060054


CONTEXT: Radioiodine refractory differentiated thyroid cancer can be effectively treated with multi-tyrosine-kinase inhibitors (MKIs). Hypocalcaemia has been reported among the side effects of these drugs, but little is known about its pathophysiology and clinical relevance. CASE REPORT: We report the case of a 78-years-old woman with an aggressive papillary thyroid cancer infiltrating perithyroidal structures. The extent of surgery was limited to hemithyroidectomy, RAI treatment could not be performed, and she started lenvatinib treatment. After 4 months of therapy, the patient accessed the Emergency Department for a grade III hypocalcaemia (corrected serum calcium: 6.6 mg/dL, n.v. 8.1-10.4 mg/dL), due to primary hypoparathyroidism (serum PTH: 12.6 ng/L, n.v. 13-64 ng/L). The patient was treated with intravenous calcium infusions and vitamin D supplementation. After discharge, the oral dose of carbonate calcium (CaCO3) was of 6 g/day, and was titrated according to blood exams. Two weeks after discharge, while taking CaCO3 at the dose of 3 g/day, the patient experienced symptomatic grade II hypercalcemia (corrected serum calcium: 11.6 mg/dL), associated to the spontaneous reprise of PTH secretion, and leading to oral calcium withdrawal. During the subsequent follow-up, the patient remained eucalcemic without calcium supplementation. CONCLUSIONS: Though hypocalcaemia has been described as potential side effect of MKI treatment, this is the first report of a lenvatinib-induced primary hypoparathyroidism, in a patient with a documented normal parathyroid function after surgery. The periodical assessment of calcium-phosphorus metabolism is thus warranted to prevent this potentially lethal side effect, in both post-surgical hypoparathyroid and euparathyroid patients.

Hypocalcemia , Hypoparathyroidism , Thyroid Neoplasms , Aged , Calcium , Female , Humans , Hypoparathyroidism/chemically induced , Hypoparathyroidism/drug therapy , Iodine Radioisotopes/therapeutic use , Parathyroid Hormone , Phenylurea Compounds , Quinolines , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/etiology , Thyroid Neoplasms/surgery , Thyroidectomy/adverse effects
J Endocrinol Invest ; 44(5): 1065-1073, 2021 May.
Article in English | MEDLINE | ID: covidwho-739704


OBJECTIVE: We compared demographic and clinic-pathological variables related to the number of surgeries for thyroid conditions or for cancer, morbidity, and fine needle aspiration (FNA) practices among Covid19 pandemic phases I, II, III and the same seasonal periods in 2019. METHODS: The prospective database of the Division of Thyroid Surgery, China-Japan Union Hospital of Jilin University, Changchun, China was used for this study. Covid19 emergency levels were stratified according to the World Health Organization: phase I (January 25-February 25, 2020), phase II (February 26-March 19), phase III (March 20-April 20). RESULTS: There were fewer outpatient FNAs and surgeries in 2020 than in 2019. There were no thyroid surgeries during phase I. There were also fewer surgeries for cancer with a significant reduction of advanced stage cancer treatments, mainly stage T1b N1a in phase II and T3bN1b in phase III. Operative times and postoperative stays were significantly shorter during the pandemic compared to our institutional baseline. In phase III, vocal cord paralysis (VCP) increased to 4.3% of our baseline numbers (P = 0.001). There were no cases of Covid19-related complications during the perioperative period. No patients required re-admission to the hospital. CONCLUSION: The Covid19 outbreak reduced thyroid surgery patient volumes. The decrease of Covid19 emergency plans contributed to unexpected outcomes (reduction of early stage cancer treatment, decreased operative times and hospital stays, increased VCP rate).

COVID-19 , Pandemics , Thyroid Diseases/surgery , Thyroid Gland/surgery , Adult , Aged , Biopsy, Fine-Needle/statistics & numerical data , China , Female , Humans , Iran , Italy , Length of Stay , Male , Middle Aged , Neoplasm Staging , Operative Time , Postoperative Complications/epidemiology , Recurrent Laryngeal Nerve Injuries/epidemiology , Republic of Korea , Thyroid Diseases/pathology , Thyroid Gland/pathology , Thyroid Neoplasms/pathology , Thyroid Neoplasms/surgery , Thyroidectomy/adverse effects , Vocal Cord Paralysis/epidemiology , Vocal Cord Paralysis/etiology